Lu/BCAM is found to be upregulated in liver cancer tissues, including poorly and well-differentiated tumors, and interacts with integrin α6β1 to competitively bind laminin, modulating the adhesion capacity of liver cancer cells. This evidence concerns the gene LAMB2 and liver cancer.